Genpact (G) Financials

$43.02 -0.44 (-1.01%)

Closing price 03:59 PM Eastern

Extended Trading

$42.97 -0.05 (-0.11%)

As of 07:24 PM Eastern

Annual Income Statements for Genpact

This table shows Genpact's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	514	631	353	369	308	305	564	263	270	240
Consolidated Net Income / (Loss)	514	631	353	369	308	305	563	261	268	240
Net Income / (Loss) Continuing Operations	514	631	353	369	308	305	281	261	268	240
Total Pre-Tax Income	677	602	465	483	400	399	362	321	330	302
Total Operating Income	702	631	502	509	439	429	348	331	341	334
Total Gross Profit	1,690	1,571	1,536	1,432	1,291	1,226	1,079	1,055	1,016	967
Total Revenue	4,767	4,477	4,371	4,022	3,709	3,521	3,001	2,737	2,571	2,461
Operating Revenue	4,767	4,477	4,371	4,022	3,709	3,521	3,001	2,737	2,571	2,461
Total Cost of Revenue	3,077	2,906	2,835	2,590	2,418	2,295	1,922	1,681	1,554	1,494
Operating Cost of Revenue	3,077	2,906	2,835	2,590	2,418	2,295	1,922	1,681	1,554	1,494
Total Operating Expenses	988	940	1,034	923	853	796	731	724	675	633
Selling, General & Admin Expense	967	913	938	866	790	795	694	689	653	608
Amortization Expense	26	31	43	58	43	33	39	36	27	29
Other Operating Expenses / (Income)	-5.62	-4.72	53	-1.20	19	-31	-1.85	-1.66	-4.94	-3.32
Total Other Income / (Expense), net	-25	-29	-37	-26	-38	-30	14	-11	-12	-32
Interest & Investment Income	-47	-48	-52	-51	-49	-43	-37	-36	-24	-42
Other Income / (Expense), net	22	19	15	26	11	14	51	26	12	9.63
Income Tax Expense	163	-29	112	114	92	95	81	60	62	62
Basic Earnings per Share	$2.88	$3.46	$1.92	$1.97	$1.62	$1.60	$1.48	$1.36	$1.30	$1.11
Weighted Average Basic Shares Outstanding	178.39M	182.35M	184.18M	187.80M	190.40M	190.07M	190.67M	193.86M	206.86M	216.61M
Diluted Earnings per Share	$2.85	$3.41	$1.88	$1.91	$1.57	$1.56	$1.45	$1.34	$1.28	$1.09
Weighted Average Diluted Shares Outstanding	180.44M	185.14M	188.09M	192.96M	195.78M	195.16M	193.98M	197.05M	210.13M	219.15M
Weighted Average Basic & Diluted Shares Outstanding	175.67M	180.73M	183.98M	185.17M	188.14M	190.40M	190.60M	193.50M	207.40M	216.10M
Cash Dividends to Common per Share	$0.61	$0.55	$0.13	$0.11	$0.39	$0.34	$0.30	$0.24	$0.00	-

This table shows Genpact's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	142	133	122	117	291	118	116	106	90	96
Consolidated Net Income / (Loss)	142	133	122	117	291	118	116	106	90	96
Net Income / (Loss) Continuing Operations	142	133	122	117	291	118	116	106	90	96
Total Pre-Tax Income	183	175	162	156	158	155	150	138	123	121
Total Operating Income	190	182	170	160	163	166	157	145	128	131
Total Gross Profit	446	431	416	396	408	403	390	370	385	394
Total Revenue	1,249	1,211	1,176	1,131	1,146	1,136	1,106	1,089	1,103	1,111
Operating Revenue	1,249	1,211	1,176	1,131	1,146	1,136	1,106	1,089	1,103	1,111
Total Cost of Revenue	803	780	760	735	739	733	715	719	717	717
Operating Cost of Revenue	803	780	760	735	739	733	715	719	717	717
Total Operating Expenses	256	250	246	236	245	237	233	225	257	263
Selling, General & Admin Expense	249	243	240	235	237	230	229	216	237	231
Amortization Expense	6.50	6.50	6.56	6.93	7.45	7.50	8.26	8.26	9.86	11
Other Operating Expenses / (Income)	-0.06	-0.02	-0.07	-5.47	-0.05	-0.09	-4.96	0.39	11	21
Total Other Income / (Expense), net	-7.63	-6.16	-7.83	-3.62	-4.26	-11	-6.95	-6.64	-4.63	-9.77
Interest & Investment Income	-11	-12	-14	-10	-13	-13	-12	-9.63	-16	-13
Other Income / (Expense), net	3.42	6.22	5.70	6.62	8.66	2.47	5.19	2.99	11	3.63
Income Tax Expense	41	43	40	39	-133	37	34	32	33	25
Basic Earnings per Share	$0.80	$0.75	$0.68	$0.65	$1.60	$0.65	$0.63	$0.58	$0.49	$0.52
Weighted Average Basic Shares Outstanding	178.39M	177.60M	179.65M	180.42M	182.35M	181.40M	183.23M	183.80M	184.18M	183.31M
Diluted Earnings per Share	$0.80	$0.74	$0.67	$0.64	$1.57	$0.64	$0.63	$0.57	$0.48	$0.51
Weighted Average Diluted Shares Outstanding	180.44M	179.71M	180.91M	181.94M	185.14M	183.80M	185.83M	187.59M	188.09M	187.40M
Weighted Average Basic & Diluted Shares Outstanding	175.67M	176.36M	178.18M	179.98M	180.73M	181.41M	181.32M	184.15M	183.98M	183.26M

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	85	-71	-164	239	226	110	-72	44	-13	8.08
Net Cash From Operating Activities	615	491	444	694	584	428	340	359	346	327
Net Cash From Continuing Operating Activities	615	491	444	694	584	428	341	359	346	327
Net Income / (Loss) Continuing Operations	514	631	353	369	308	305	283	261	268	240
Consolidated Net Income / (Loss)	514	631	353	369	308	305	281	261	268	240
Depreciation Expense	70	73	87	109	116	96	65	59	55	54
Amortization Expense	29	33	45	61	46	34	43	38	29	42
Non-Cash Adjustments To Reconcile Net Income	-6.86	55	138	160	20	-14	-17	9.64	-15	37
Changes in Operating Assets and Liabilities, net	9.94	-301	-180	-5.54	94	6.25	-33	-8.20	10	-46
Net Cash From Investing Activities	-106	-79	-37	-123	-266	-357	-276	-362	-126	-100
Net Cash From Continuing Investing Activities	-106	-79	-37	-123	-266	-357	-276	-362	-126	-100
Purchase of Property, Plant & Equipment	-83	-55	-51	-53	-70	-75	-85	-57	-82	-62
Acquisitions	-2.47	-4.04	-3.81	-76	-197	-34	-187	-306	-62	-40
Purchase of Investments	-23	0.00	0.00	-	-	-	-	-	-	-
Sale of Property, Plant & Equipment	2.64	0.03	0.06	6.38	0.61	1.75	0.67	1.74	0.55	1.49
Divestitures	0.00	-20	18	0.14	0.00	-250	0.00	-	17	-
Net Cash From Financing Activities	-425	-483	-571	-333	-92	40	-135	47	-233	-219
Net Cash From Continuing Financing Activities	-425	-483	-571	-333	-92	40	-135	47	-233	-219
Repayment of Debt	-509	-321	-746	-301	-475	-661	-295	-328	-103	-2,258
Repurchase of Common Equity	-253	-225	-214	-298	-137	-30	-154	-220	-345	-227
Payment of Dividends	-108	-100	-92	-80	-74	-65	-57	-47	-	-
Issuance of Debt	450	148	500	350	610	800	379	645	200	2,252
Issuance of Common Equity	17	39	28	35	25	20	14	16	18	16
Other Financing Activities, net	-22	-24	-47	-38	-41	-24	-22	-19	-2.25	-0.86
Cash Interest Paid	69	48	51	46	49	45	41	28	20	21
Cash Income Taxes Paid	114	157	146	32	194	104	81	66	47	72

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-355	98	440	-98	28	67	-57	-109	130	104
Net Cash From Operating Activities	203	228	209	-26	192	162	171	-34	230	226
Net Cash From Continuing Operating Activities	203	228	209	-26	192	162	171	-34	230	226
Net Income / (Loss) Continuing Operations	142	133	122	117	291	118	116	106	90	96
Consolidated Net Income / (Loss)	142	133	122	117	291	118	116	106	90	96
Depreciation Expense	18	17	17	17	18	18	18	19	19	20
Amortization Expense	7.16	7.21	7.11	7.42	7.95	7.99	8.75	8.74	10	11
Non-Cash Adjustments To Reconcile Net Income	-53	36	19	-8.95	92	-23	-24	9.87	95	18
Changes in Operating Assets and Liabilities, net	89	35	44	-158	-218	42	52	-178	16	81
Net Cash From Investing Activities	-41	-20	-20	-25	-19	-14	-12	-34	0.66	-8.23
Net Cash From Continuing Investing Activities	-41	-20	-20	-25	-19	-14	-12	-34	0.66	-8.23
Purchase of Property, Plant & Equipment	-20	-20	-19	-24	-18	-13	-11	-13	-15	-8.37
Acquisitions	-0.68	-0.53	-0.59	-0.67	19	-0.86	-0.88	-21	-1.81	0.13
Sale of Property, Plant & Equipment	2.51	0.01	0.12	0.00	0.00	0.00	0.01	0.01	0.00	0.02
Net Cash From Financing Activities	-517	-110	251	-48	-145	-81	-216	-41	-100	-114
Net Cash From Continuing Financing Activities	-517	-110	251	-48	-145	-81	-216	-41	-100	-114
Repayment of Debt	-410	-10	-62	-27	-48	-57	-160	-56	-310	-63
Payment of Dividends	-27	-27	-27	-27	-25	-25	-25	-25	-23	-23
Issuance of Common Equity	5.05	2.45	2.92	6.80	4.85	2.71	16	16	15	4.60
Other Financing Activities, net	-0.97	-0.17	-0.32	-21	-1.84	-1.37	-0.15	-21	-	-2.86
Cash Interest Paid	30	8.56	19	11	16	9.00	16	6.11	21	7.26
Cash Income Taxes Paid	36	32	26	20	33	57	44	23	32	36

This table presents Genpact's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	4,987	4,806	4,589	4,975	4,874	4,454	3,529	3,450	2,886	2,793
Total Current Assets	2,080	1,892	1,779	1,922	1,749	1,552	1,355	1,434	1,227	1,195
Cash & Equivalents	648	584	647	899	680	467	368	504	423	451
Short-Term Investments	23	0.00	-	-	-	-	-	-	-	-
Accounts Receivable	1,199	1,116	995	888	881	914	774	693	615	590
Prepaid Expenses	210	192	138	134	187	170	212	236	189	154
Plant, Property, & Equipment, net	208	190	181	215	231	254	213	207	193	175
Total Noncurrent Assets	2,699	2,724	2,629	2,839	2,894	2,648	1,962	1,809	1,466	1,423
Goodwill	1,670	1,684	1,684	1,731	1,696	1,574	1,394	1,337	1,069	1,038
Intangible Assets	27	53	90	170	237	231	177	132	79	99
Noncurrent Deferred & Refundable Income Taxes	269	299	135	106	107	90	75	77	70	99
Other Noncurrent Operating Assets	733	689	719	832	854	753	315	262	242	180
Total Liabilities & Shareholders' Equity	4,987	4,806	4,589	4,975	4,874	4,454	3,529	3,450	2,886	2,793
Total Liabilities	2,598	2,557	2,763	3,078	3,039	2,765	2,125	2,021	1,595	1,489
Total Current Liabilities	964	1,318	1,103	1,309	1,203	910	976	839	731	594
Short-Term Debt	26	442	177	383	284	104	328	209	199	61
Accounts Payable	36	28	36	25	14	22	43	15	9.77	10
Current Deferred & Payable Income Tax Liabilities	35	38	45	47	42	43	34	30	24	24
Other Current Liabilities	866	809	845	853	863	742	571	584	498	500
Total Noncurrent Liabilities	1,634	1,239	1,659	1,769	1,837	1,855	1,149	1,182	863	895
Long-Term Debt	1,195	825	1,249	1,272	1,307	1,340	976	1,007	698	737
Noncurrent Deferred & Payable Income Tax Liabilities	16	12	4.18	3.94	1.52	3.99	8.08	6.75	2.42	2.09
Other Noncurrent Operating Liabilities	423	403	406	493	528	511	165	169	163	155
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,390	2,248	1,826	1,897	1,834	1,689	1,404	1,424	1,287	1,304
Total Preferred & Common Equity	2,390	2,248	1,826	1,897	1,834	1,689	1,404	1,424	1,287	1,304
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,390	2,248	1,826	1,897	1,834	1,689	1,404	1,424	1,287	1,304
Common Stock	1,947	1,886	1,779	1,719	1,638	1,572	1,473	1,423	1,386	1,344
Retained Earnings	1,237	1,085	780	732	742	649	438	356	358	412
Accumulated Other Comprehensive Income / (Loss)	-794	-723	-733	-554	-545	-532	-507	-355	-458	-451

This table presents Genpact's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	5,326	5,178	4,741	4,599	4,482	4,506	4,537
Total Current Assets	2,401	2,266	1,830	1,870	1,748	1,734	1,758
Cash & Equivalents	1,023	914	478	541	491	552	519
Accounts Receivable	1,214	1,160	1,147	1,054	1,008	1,005	994
Prepaid Expenses	164	192	205	274	249	176	230
Plant, Property, & Equipment, net	208	200	194	180	180	179	180
Total Noncurrent Assets	2,717	2,713	2,716	2,550	2,554	2,593	2,598
Goodwill	1,683	1,678	1,680	1,678	1,685	1,687	1,681
Intangible Assets	33	40	46	62	71	80	101
Noncurrent Deferred & Refundable Income Taxes	289	277	282	138	131	131	112
Other Noncurrent Operating Assets	712	718	708	672	667	695	704
Total Liabilities & Shareholders' Equity	5,326	5,178	4,741	4,599	4,482	4,506	4,537
Total Liabilities	2,931	2,841	2,442	2,589	2,549	2,581	2,805
Total Current Liabilities	1,295	1,198	1,185	979	931	945	1,633
Short-Term Debt	426	426	476	81	129	206	735
Accounts Payable	19	28	28	27	42	23	28
Current Deferred & Payable Income Tax Liabilities	53	44	39	131	94	64	107
Other Current Liabilities	797	700	642	740	667	652	754
Total Noncurrent Liabilities	1,636	1,643	1,257	1,610	1,618	1,636	1,172
Long-Term Debt	1,201	1,208	818	1,230	1,237	1,243	747
Noncurrent Deferred & Payable Income Tax Liabilities	12	10	12	3.82	3.79	4.49	3.63
Other Noncurrent Operating Liabilities	423	425	427	376	378	389	421
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,395	2,338	2,298	2,009	1,933	1,925	1,732
Total Preferred & Common Equity	2,395	2,338	2,298	2,009	1,933	1,925	1,732
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,395	2,338	2,298	2,009	1,933	1,925	1,732
Common Stock	1,924	1,902	1,881	1,858	1,833	1,797	1,742
Retained Earnings	1,207	1,176	1,145	894	801	831	745
Accumulated Other Comprehensive Income / (Loss)	-736	-740	-727	-742	-701	-702	-755

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.48%	2.42%	8.68%	8.43%	5.36%	17.32%	9.64%	6.46%	4.46%	7.97%
EBITDA Growth	8.81%	16.45%	-7.87%	15.25%	6.65%	13.13%	11.72%	3.86%	-0.77%	20.06%
EBIT Growth	11.36%	25.65%	-3.20%	18.94%	1.48%	10.96%	11.85%	0.94%	2.82%	21.16%
NOPAT Growth	-19.42%	73.36%	-2.00%	15.26%	3.04%	21.17%	0.35%	-2.67%	4.27%	17.32%
Net Income Growth	-18.63%	78.62%	-4.34%	19.84%	1.11%	-45.87%	115.95%	-2.51%	11.56%	24.79%
EPS Growth	-16.42%	81.38%	-1.57%	21.66%	0.64%	7.59%	8.21%	4.69%	17.43%	28.24%
Operating Cash Flow Growth	25.39%	10.63%	-36.10%	18.82%	36.56%	26.03%	-5.45%	3.85%	5.60%	20.45%
Free Cash Flow Firm Growth	56.61%	-21.91%	-10.62%	85.90%	17,755.38%	-97.95%	165.08%	-167.71%	-30.87%	693.80%
Invested Capital Growth	0.26%	12.51%	-1.81%	-3.32%	2.98%	13.95%	9.34%	21.48%	7.07%	2.07%
Revenue Q/Q Growth	2.20%	0.99%	0.70%	3.12%	0.27%	3.09%	3.48%	1.96%	1.39%	1.86%
EBITDA Q/Q Growth	2.65%	4.09%	1.47%	0.95%	-1.30%	2.91%	5.61%	-1.29%	3.47%	-1.43%
EBIT Q/Q Growth	3.16%	5.31%	4.36%	1.09%	-2.83%	1.89%	7.22%	-3.07%	4.06%	-1.57%
NOPAT Q/Q Growth	-22.25%	46.41%	3.84%	-1.44%	-0.33%	1.10%	9.39%	-6.97%	5.32%	3.73%
Net Income Q/Q Growth	-22.53%	46.92%	4.94%	-0.51%	-2.29%	-47.78%	109.98%	-3.67%	4.55%	8.44%
EPS Q/Q Growth	-21.27%	46.98%	5.62%	0.00%	-2.48%	0.65%	5.07%	-2.19%	5.79%	9.00%
Operating Cash Flow Q/Q Growth	1.88%	-7.14%	-3.73%	14.46%	14.17%	-10.49%	13.86%	-3.85%	11.59%	-5.53%
Free Cash Flow Firm Q/Q Growth	12.73%	-6.70%	14.83%	78.96%	73.09%	-99.18%	-35.59%	-93.99%	21.95%	-25.81%
Invested Capital Q/Q Growth	-2.00%	5.46%	-3.05%	-1.51%	6.89%	12.07%	4.88%	2.22%	0.80%	1.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.45%	35.08%	35.15%	35.60%	34.81%	34.82%	35.96%	38.56%	39.54%	39.31%
EBITDA Margin	17.26%	16.89%	14.85%	17.52%	16.49%	16.29%	16.89%	16.58%	16.99%	17.89%
Operating Margin	14.73%	14.09%	11.49%	12.65%	11.83%	12.20%	11.60%	12.10%	13.27%	13.58%
EBIT Margin	15.19%	14.52%	11.84%	13.29%	12.12%	12.58%	13.30%	13.04%	13.75%	13.97%
Profit (Net Income) Margin	10.78%	14.10%	8.08%	9.19%	8.31%	8.66%	18.77%	9.53%	10.41%	9.74%
Tax Burden Percent	75.89%	104.82%	75.96%	76.47%	76.98%	76.33%	155.59%	81.36%	81.16%	79.47%
Interest Burden Percent	93.48%	92.63%	89.91%	90.38%	89.11%	90.18%	90.70%	89.83%	93.24%	87.76%
Effective Tax Rate	24.11%	-4.82%	24.04%	23.53%	23.02%	23.67%	22.31%	18.64%	18.84%	20.53%
Return on Invested Capital (ROIC)	18.15%	23.88%	14.51%	14.42%	12.48%	13.10%	12.08%	13.82%	16.26%	16.31%
ROIC Less NNEP Spread (ROIC-NNEP)	15.04%	19.78%	10.85%	12.05%	9.36%	10.71%	47.67%	12.35%	13.95%	8.58%
Return on Net Nonoperating Assets (RNNOA)	4.00%	7.10%	4.48%	5.38%	5.01%	6.61%	27.69%	5.36%	4.35%	2.21%
Return on Equity (ROE)	22.15%	30.99%	18.98%	19.80%	17.50%	19.71%	39.77%	19.18%	20.62%	18.52%
Cash Return on Invested Capital (CROIC)	17.89%	12.11%	16.33%	17.80%	9.55%	0.06%	3.16%	-5.58%	9.43%	14.27%
Operating Return on Assets (OROA)	14.79%	13.84%	10.82%	10.86%	9.64%	11.10%	11.44%	11.27%	12.45%	12.42%
Return on Assets (ROA)	10.49%	13.44%	7.39%	7.50%	6.61%	7.64%	16.14%	8.23%	9.42%	8.66%
Return on Common Equity (ROCE)	22.15%	30.99%	18.98%	19.80%	17.50%	19.71%	39.70%	19.11%	20.58%	18.52%
Return on Equity Simple (ROE_SIMPLE)	21.50%	28.08%	19.35%	19.47%	16.81%	18.05%	40.11%	18.32%	20.79%	18.39%
Net Operating Profit after Tax (NOPAT)	533	661	381	389	338	328	270	270	277	266
NOPAT Margin	11.18%	14.77%	8.73%	9.68%	9.10%	9.31%	9.01%	9.85%	10.77%	10.79%
Net Nonoperating Expense Percent (NNEP)	3.11%	4.10%	3.65%	2.37%	3.12%	2.39%	-35.59%	1.47%	2.32%	7.73%
Return On Investment Capital (ROIC_SIMPLE)	14.76%	18.81%	11.73%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	64.55%	64.92%	64.85%	64.40%	65.19%	65.18%	64.04%	61.44%	60.46%	60.69%
SG&A Expenses to Revenue	20.29%	20.40%	21.47%	21.52%	21.29%	22.58%	23.12%	25.19%	25.40%	24.71%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	20.73%	20.99%	23.66%	22.95%	22.98%	22.62%	24.36%	26.46%	26.27%	25.73%
Earnings before Interest and Taxes (EBIT)	724	650	517	535	449	443	399	357	354	344
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	823	756	649	705	612	573	507	454	437	440
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.17	2.76	4.51	5.08	4.09	4.49	3.43	4.00	3.50	3.75
Price to Tangible Book Value (P/TBV)	10.93	12.11	157.57	0.00	0.00	0.00	0.00	0.00	32.57	29.25
Price to Revenue (P/Rev)	1.59	1.38	1.88	2.40	2.02	2.16	1.61	2.08	1.75	1.99
Price to Earnings (P/E)	14.75	9.81	23.29	26.10	24.31	24.90	8.54	21.65	16.70	20.42
Dividend Yield	1.42%	1.61%	1.11%	0.84%	0.99%	0.85%	1.18%	0.81%	0.00%	0.00%
Earnings Yield	6.78%	10.19%	4.29%	3.83%	4.11%	4.02%	11.71%	4.62%	5.99%	4.90%
Enterprise Value to Invested Capital (EV/IC)	2.76	2.35	3.46	3.92	3.06	3.21	2.46	3.00	2.83	3.18
Enterprise Value to Revenue (EV/Rev)	1.70	1.54	2.06	2.59	2.27	2.43	1.92	2.34	1.94	2.13
Enterprise Value to EBITDA (EV/EBITDA)	9.88	9.10	13.88	14.75	13.75	14.94	11.35	14.13	11.40	11.90
Enterprise Value to EBIT (EV/EBIT)	11.22	10.58	17.42	19.45	18.70	19.34	14.41	17.97	14.08	15.23
Enterprise Value to NOPAT (EV/NOPAT)	15.25	10.40	23.63	26.71	24.89	26.14	21.27	23.79	17.98	19.72
Enterprise Value to Operating Cash Flow (EV/OCF)	13.20	14.01	20.31	14.98	14.39	20.02	16.94	17.86	14.40	15.99
Enterprise Value to Free Cash Flow (EV/FCFF)	15.47	20.52	20.99	21.65	32.53	5,919.40	81.30	0.00	31.00	22.54
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.51	0.56	0.78	0.87	0.87	0.85	0.93	0.85	0.70	0.61
Long-Term Debt to Equity	0.50	0.37	0.68	0.67	0.71	0.79	0.69	0.70	0.54	0.57
Financial Leverage	0.27	0.36	0.41	0.45	0.54	0.62	0.58	0.43	0.31	0.26
Leverage Ratio	2.11	2.31	2.57	2.64	2.65	2.58	2.46	2.33	2.19	2.14
Compound Leverage Factor	1.97	2.14	2.31	2.39	2.36	2.33	2.23	2.09	2.04	1.88
Debt to Total Capital	33.83%	36.04%	43.85%	46.61%	46.45%	46.08%	48.15%	45.98%	41.00%	37.96%
Short-Term Debt to Total Capital	0.72%	12.58%	5.45%	10.79%	8.28%	3.30%	12.13%	7.91%	9.10%	2.88%
Long-Term Debt to Total Capital	33.10%	23.46%	38.41%	35.81%	38.17%	42.77%	36.02%	38.06%	31.90%	35.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	0.21%	0.00%
Common Equity to Total Capital	66.17%	63.96%	56.15%	53.39%	53.55%	53.92%	51.85%	53.85%	58.79%	62.04%
Debt to EBITDA	1.48	1.68	2.20	2.35	2.60	2.52	2.57	2.68	2.05	1.81
Net Debt to EBITDA	0.67	0.90	1.20	1.07	1.49	1.70	1.84	1.57	1.08	0.77
Long-Term Debt to EBITDA	1.45	1.09	1.92	1.81	2.14	2.34	1.92	2.22	1.60	1.68
Debt to NOPAT	2.29	1.92	3.74	4.25	4.71	4.40	4.82	4.51	3.24	3.00
Net Debt to NOPAT	1.03	1.03	2.04	1.94	2.70	2.98	3.46	2.64	1.70	1.28
Long-Term Debt to NOPAT	2.24	1.25	3.27	3.27	3.87	4.09	3.61	3.73	2.52	2.78
Altman Z-Score	3.80	3.29	3.53	3.40	2.89	3.14	2.89	3.18	3.37	3.72
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.17%	0.34%	0.17%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.16	1.44	1.61	1.47	1.45	1.70	1.39	1.71	1.68	2.01
Quick Ratio	1.94	1.29	1.49	1.37	1.30	1.52	1.17	1.43	1.42	1.75
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	525	335	429	480	258	1.45	71	-109	161	232
Operating Cash Flow to CapEx	768.02%	886.01%	877.62%	1,478.55%	839.97%	584.73%	402.69%	647.07%	424.89%	539.56%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.97	0.95	0.91	0.82	0.80	0.88	0.86	0.86	0.91	0.89
Accounts Receivable Turnover	4.12	4.24	4.64	4.55	4.13	4.17	4.09	4.18	4.27	4.41
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	23.97	24.16	22.09	18.03	15.29	15.09	14.30	13.68	13.95	14.01
Accounts Payable Turnover	95.85	91.47	93.26	133.20	134.75	71.08	66.69	135.50	156.58	116.55
Days Sales Outstanding (DSO)	88.62	86.06	78.60	80.25	88.33	87.53	89.24	87.24	85.57	82.75
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	3.81	3.99	3.91	2.74	2.71	5.14	5.47	2.69	2.33	3.13
Cash Conversion Cycle (CCC)	84.81	82.07	74.68	77.51	85.62	82.39	83.76	84.55	83.24	79.62
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,939	2,932	2,606	2,654	2,745	2,665	2,339	2,139	1,761	1,645
Invested Capital Turnover	1.62	1.62	1.66	1.49	1.37	1.41	1.34	1.40	1.51	1.51
Increase / (Decrease) in Invested Capital	7.76	326	-48	-91	79	326	200	378	116	33
Enterprise Value (EV)	8,125	6,878	9,012	10,398	8,406	8,566	5,752	6,412	4,978	5,237
Market Capitalization	7,575	6,195	8,232	9,642	7,495	7,590	4,817	5,697	4,504	4,897
Book Value per Share	$13.55	$12.39	$9.96	$10.09	$9.69	$8.89	$7.39	$7.38	$6.41	$6.13
Tangible Book Value per Share	$3.93	$2.82	$0.29	($0.02)	($0.52)	($0.61)	($0.88)	($0.23)	$0.69	$0.79
Total Capital	3,611	3,515	3,252	3,553	3,425	3,132	2,708	2,645	2,189	2,102
Total Debt	1,221	1,267	1,426	1,656	1,591	1,443	1,304	1,216	897	798
Total Long-Term Debt	1,195	825	1,249	1,272	1,307	1,340	976	1,007	698	737
Net Debt	550	683	780	756	910	976	935	711	470	340
Capital Expenditures (CapEx)	80	55	51	47	70	73	84	55	81	61
Debt-free, Cash-free Net Working Capital (DFCFNWC)	471	432	207	97	149	278	339	300	272	210
Debt-free Net Working Capital (DFNWC)	1,143	1,016	853	996	830	745	707	804	695	661
Net Working Capital (NWC)	1,116	574	676	613	546	641	379	595	496	601
Net Nonoperating Expense (NNE)	19	30	28	20	29	23	-293	8.70	9.38	26
Net Nonoperating Obligations (NNO)	550	683	780	756	910	976	935	711	470	340
Total Depreciation and Amortization (D&A)	99	106	132	170	162	130	108	97	83	96
Debt-free, Cash-free Net Working Capital to Revenue	9.88%	9.65%	4.73%	2.41%	4.03%	7.89%	11.29%	10.96%	10.59%	8.55%
Debt-free Net Working Capital to Revenue	23.97%	22.69%	19.52%	24.77%	22.37%	21.16%	23.57%	29.39%	27.03%	26.87%
Net Working Capital to Revenue	23.42%	12.81%	15.47%	15.24%	14.73%	18.22%	12.62%	21.74%	19.28%	24.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.88	$3.46	$1.92	$1.97	$1.62	$1.60	$1.48	$1.36	$1.30	$1.11
Adjusted Weighted Average Basic Shares Outstanding	178.39M	182.35M	184.18M	187.80M	190.40M	190.07M	190.67M	193.86M	206.86M	216.61M
Adjusted Diluted Earnings per Share	$2.85	$3.41	$1.88	$1.91	$1.57	$1.56	$1.45	$1.34	$1.28	$1.09
Adjusted Weighted Average Diluted Shares Outstanding	180.44M	185.14M	188.09M	192.96M	195.78M	195.16M	193.98M	197.05M	210.13M	219.15M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	175.67M	180.73M	183.98M	185.17M	188.14M	190.40M	189.46M	193.48M	198.97M	210.55M
Normalized Net Operating Profit after Tax (NOPAT)	533	442	381	389	338	328	270	270	277	266
Normalized NOPAT Margin	11.18%	9.86%	8.73%	9.68%	9.10%	9.31%	9.01%	9.85%	10.77%	10.79%
Pre Tax Income Margin	14.20%	13.45%	10.64%	12.01%	10.80%	11.35%	12.06%	11.71%	12.82%	12.26%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	21.12%	15.84%	25.99%	21.78%	24.07%	21.21%	10.14%	17.90%	0.00%	0.00%
Augmented Payout Ratio	70.31%	51.57%	86.56%	102.50%	68.55%	31.06%	37.51%	102.16%	129.13%	94.70%

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.94%	6.62%	6.39%	3.85%	3.96%	2.23%	1.50%	1.95%	2.82%	9.38%
EBITDA Growth	10.76%	9.63%	5.80%	8.94%	17.73%	16.74%	34.24%	0.57%	5.95%	-6.58%
EBIT Growth	12.96%	11.72%	8.27%	12.50%	23.63%	25.05%	52.49%	7.50%	18.49%	-1.49%
NOPAT Growth	-50.58%	9.30%	5.14%	7.61%	221.35%	21.44%	47.55%	8.53%	18.08%	-5.38%
Net Income Growth	-51.28%	12.95%	4.94%	10.22%	224.72%	22.69%	62.20%	10.32%	22.75%	-6.39%
EPS Growth	-49.04%	15.63%	6.35%	12.28%	227.08%	25.49%	65.79%	11.76%	26.32%	-3.77%
Operating Cash Flow Growth	5.91%	41.44%	22.06%	24.96%	-16.43%	-28.53%	67.54%	70.19%	-6.96%	7.76%
Free Cash Flow Firm Growth	621.41%	-345.14%	-216.35%	-199.80%	-119.06%	-69.61%	108.88%	3,943.10%	-17.04%	746.94%
Invested Capital Growth	0.26%	7.90%	8.90%	10.35%	12.51%	3.43%	0.60%	-2.13%	-1.81%	-0.24%
Revenue Q/Q Growth	3.12%	2.95%	3.98%	-1.31%	0.92%	2.74%	1.49%	-1.20%	-0.76%	2.01%
EBITDA Q/Q Growth	2.98%	6.01%	4.71%	-3.12%	1.93%	2.31%	7.83%	4.70%	1.07%	17.65%
EBIT Q/Q Growth	3.05%	6.77%	5.61%	-2.79%	1.92%	3.48%	9.73%	6.83%	3.09%	26.19%
NOPAT Q/Q Growth	7.54%	7.51%	6.87%	-60.00%	137.82%	3.42%	9.39%	19.44%	-10.12%	25.65%
Net Income Q/Q Growth	6.85%	8.88%	4.31%	-59.85%	147.73%	1.15%	9.57%	18.27%	-6.40%	33.73%
EPS Q/Q Growth	8.11%	10.45%	4.69%	-59.24%	145.31%	1.59%	10.53%	18.75%	-5.88%	34.21%
Operating Cash Flow Q/Q Growth	-11.04%	9.17%	918.72%	-113.32%	18.81%	-5.79%	603.31%	-114.83%	1.61%	120.84%
Free Cash Flow Firm Q/Q Growth	270.73%	32.68%	29.27%	-541.39%	-180.27%	-68.05%	-39.33%	22.46%	28.01%	119.63%
Invested Capital Q/Q Growth	-2.00%	-1.88%	-1.83%	6.22%	5.46%	-0.97%	-0.52%	8.31%	-3.05%	-3.68%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.70%	35.63%	35.40%	35.05%	35.56%	35.47%	35.28%	33.99%	34.94%	35.45%
EBITDA Margin	17.51%	17.54%	17.03%	16.91%	17.23%	17.06%	17.13%	16.12%	15.21%	14.94%
Operating Margin	15.23%	15.00%	14.47%	14.14%	14.20%	14.59%	14.23%	13.32%	11.59%	11.78%
EBIT Margin	15.50%	15.51%	14.96%	14.73%	14.95%	14.81%	14.70%	13.60%	12.57%	12.10%
Profit (Net Income) Margin	11.36%	10.97%	10.37%	10.34%	25.41%	10.35%	10.52%	9.74%	8.14%	8.63%
Tax Burden Percent	77.74%	75.69%	75.11%	74.79%	183.82%	75.91%	77.31%	76.62%	72.87%	79.16%
Interest Burden Percent	94.29%	93.41%	92.31%	93.85%	92.46%	92.12%	92.53%	93.50%	88.81%	90.04%
Effective Tax Rate	22.26%	24.31%	24.89%	25.21%	-83.82%	24.09%	22.69%	23.38%	27.13%	20.84%
Return on Invested Capital (ROIC)	19.23%	18.33%	17.02%	16.10%	42.20%	17.96%	17.33%	15.71%	14.03%	15.04%
ROIC Less NNEP Spread (ROIC-NNEP)	18.26%	17.65%	16.28%	15.79%	41.13%	17.01%	16.77%	15.19%	13.60%	14.13%
Return on Net Nonoperating Assets (RNNOA)	4.86%	5.51%	6.08%	6.40%	14.77%	7.85%	8.72%	7.78%	5.61%	6.51%
Return on Equity (ROE)	24.08%	23.84%	23.09%	22.50%	56.96%	25.81%	26.04%	23.50%	19.64%	21.55%
Cash Return on Invested Capital (CROIC)	17.89%	16.12%	14.50%	12.69%	12.11%	13.14%	14.74%	15.83%	16.33%	13.89%
Operating Return on Assets (OROA)	15.09%	14.58%	14.21%	14.40%	14.25%	14.37%	14.36%	12.60%	11.49%	10.96%
Return on Assets (ROA)	11.06%	10.31%	9.85%	10.10%	24.22%	10.05%	10.28%	9.03%	7.44%	7.81%
Return on Common Equity (ROCE)	24.08%	23.84%	23.09%	22.50%	56.96%	25.81%	26.04%	23.50%	19.64%	21.55%
Return on Equity Simple (ROE_SIMPLE)	0.00%	27.69%	27.71%	27.94%	0.00%	21.38%	21.10%	18.87%	0.00%	19.45%
Net Operating Profit after Tax (NOPAT)	148	137	128	120	299	126	122	111	93	104
NOPAT Margin	11.84%	11.35%	10.87%	10.58%	26.10%	11.07%	11.00%	10.21%	8.44%	9.32%
Net Nonoperating Expense Percent (NNEP)	0.96%	0.68%	0.74%	0.32%	1.07%	0.95%	0.56%	0.53%	0.44%	0.91%
Return On Investment Capital (ROIC_SIMPLE)	4.09%	-	-	-	8.51%	-	-	-	2.86%	-
Cost of Revenue to Revenue	64.30%	64.37%	64.60%	64.95%	64.44%	64.53%	64.72%	66.01%	65.06%	64.55%
SG&A Expenses to Revenue	19.95%	20.09%	20.37%	20.78%	20.71%	20.23%	20.75%	19.87%	21.46%	20.83%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	20.47%	20.63%	20.93%	20.91%	21.36%	20.88%	21.05%	20.67%	23.35%	23.67%
Earnings before Interest and Taxes (EBIT)	194	188	176	167	171	168	163	148	139	134
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	219	212	200	191	197	194	189	176	168	166
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.17	2.92	2.48	2.58	2.76	3.21	3.52	4.33	4.51	4.52
Price to Tangible Book Value (P/TBV)	10.93	10.30	9.34	10.36	12.11	23.92	38.44	52.80	157.57	0.00
Price to Revenue (P/Rev)	1.59	1.50	1.26	1.31	1.38	1.46	1.54	1.90	1.88	1.80
Price to Earnings (P/E)	14.75	10.54	8.94	9.23	9.81	15.02	16.68	22.93	23.29	23.23
Dividend Yield	1.42%	1.52%	1.80%	1.72%	1.61%	1.51%	1.42%	1.13%	1.11%	1.13%
Earnings Yield	6.78%	9.49%	11.18%	10.83%	10.19%	6.66%	6.00%	4.36%	4.29%	4.30%
Enterprise Value to Invested Capital (EV/IC)	2.76	2.53	2.13	2.17	2.35	2.60	2.74	3.27	3.46	3.27
Enterprise Value to Revenue (EV/Rev)	1.70	1.63	1.42	1.49	1.54	1.63	1.74	2.10	2.06	2.02
Enterprise Value to EBITDA (EV/EBITDA)	9.88	9.47	8.32	8.74	9.10	9.95	10.99	14.19	13.88	13.73
Enterprise Value to EBIT (EV/EBIT)	11.22	10.82	9.55	10.09	10.58	11.70	13.15	17.49	17.42	17.72
Enterprise Value to NOPAT (EV/NOPAT)	15.25	11.08	9.65	10.09	10.40	15.99	17.88	23.65	23.63	23.92
Enterprise Value to Operating Cash Flow (EV/OCF)	13.20	12.57	12.13	13.51	14.01	13.67	12.95	17.62	20.31	19.07
Enterprise Value to Free Cash Flow (EV/FCFF)	15.47	16.30	15.32	17.90	20.52	20.10	18.62	20.43	20.99	23.50
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.51	0.68	0.70	0.56	0.56	0.65	0.71	0.75	0.78	0.86
Long-Term Debt to Equity	0.50	0.50	0.52	0.36	0.37	0.61	0.64	0.65	0.68	0.43
Financial Leverage	0.27	0.31	0.37	0.41	0.36	0.46	0.52	0.51	0.41	0.46
Leverage Ratio	2.11	2.25	2.26	2.19	2.31	2.44	2.45	2.51	2.57	2.60
Compound Leverage Factor	1.99	2.10	2.09	2.05	2.13	2.25	2.27	2.35	2.28	2.34
Debt to Total Capital	33.83%	40.46%	41.13%	36.02%	36.04%	39.49%	41.40%	42.94%	43.85%	46.11%
Short-Term Debt to Total Capital	0.72%	10.59%	10.72%	13.24%	12.58%	2.44%	3.92%	6.11%	5.45%	22.88%
Long-Term Debt to Total Capital	33.10%	29.87%	30.41%	22.78%	23.46%	37.05%	37.49%	36.83%	38.41%	23.23%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	66.17%	59.54%	58.87%	63.98%	63.96%	60.51%	58.60%	57.06%	56.15%	53.89%
Debt to EBITDA	1.48	2.03	2.09	1.68	1.68	1.81	1.96	2.23	2.20	2.32
Net Debt to EBITDA	0.67	0.75	0.92	1.06	0.90	1.06	1.25	1.38	1.20	1.51
Long-Term Debt to EBITDA	1.45	1.50	1.54	1.06	1.09	1.69	1.77	1.91	1.92	1.17
Debt to NOPAT	2.29	2.37	2.42	1.94	1.92	2.90	3.18	3.71	3.74	4.03
Net Debt to NOPAT	1.03	0.88	1.07	1.22	1.03	1.71	2.04	2.30	2.04	2.62
Long-Term Debt to NOPAT	2.24	1.75	1.79	1.22	1.25	2.72	2.88	3.19	3.27	2.03
Altman Z-Score	3.45	2.99	2.79	3.03	2.96	3.08	3.17	3.49	3.26	2.99
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.16	1.85	1.89	1.54	1.44	1.91	1.88	1.84	1.61	1.08
Quick Ratio	1.94	1.73	1.73	1.37	1.29	1.63	1.61	1.65	1.49	0.93
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	140	-82	-122	-172	-27	33	105	173	141	110
Operating Cash Flow to CapEx	1,180.98%	1,156.14%	1,092.53%	-106.48%	1,061.02%	1,215.11%	1,497.74%	-271.02%	1,500.84%	2,705.17%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.97	0.94	0.95	0.98	0.95	0.97	0.98	0.93	0.91	0.91
Accounts Receivable Turnover	4.12	4.11	4.23	4.20	4.24	4.33	4.36	4.44	4.64	4.46
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	23.97	24.09	24.20	24.23	24.16	24.62	23.90	23.00	22.09	22.36
Accounts Payable Turnover	95.85	133.39	84.29	115.16	91.47	105.70	83.26	130.92	93.26	106.90
Days Sales Outstanding (DSO)	88.62	88.76	86.19	86.94	86.06	84.34	83.71	82.14	78.60	81.79
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	3.81	2.74	4.33	3.17	3.99	3.45	4.38	2.79	3.91	3.41
Cash Conversion Cycle (CCC)	84.81	86.02	81.86	83.77	82.07	80.89	79.32	79.35	74.68	78.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,939	3,000	3,057	3,114	2,932	2,780	2,807	2,822	2,606	2,688
Invested Capital Turnover	1.62	1.61	1.57	1.52	1.62	1.62	1.58	1.54	1.66	1.61
Increase / (Decrease) in Invested Capital	7.76	220	250	292	326	92	17	-61	-48	-6.57
Enterprise Value (EV)	8,125	7,591	6,513	6,744	6,878	7,224	7,678	9,229	9,012	8,787
Market Capitalization	7,575	6,986	5,794	5,928	6,195	6,453	6,804	8,332	8,232	7,824
Book Value per Share	$13.55	$13.44	$12.99	$12.72	$12.39	$11.08	$10.50	$10.46	$9.96	$9.44
Tangible Book Value per Share	$3.93	$3.81	$3.45	$3.17	$2.82	$1.49	$0.96	$0.86	$0.29	($0.27)
Total Capital	3,611	4,022	3,971	3,592	3,515	3,321	3,299	3,374	3,252	3,214
Total Debt	1,221	1,628	1,634	1,294	1,267	1,312	1,366	1,449	1,426	1,482
Total Long-Term Debt	1,195	1,201	1,208	818	825	1,230	1,237	1,243	1,249	747
Net Debt	550	605	719	816	683	771	875	897	780	963
Capital Expenditures (CapEx)	17	20	19	24	18	13	11	13	15	8.35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	471	510	580	642	432	431	455	443	207	342
Debt-free Net Working Capital (DFNWC)	1,143	1,532	1,494	1,121	1,016	972	946	995	853	860
Net Working Capital (NWC)	1,116	1,106	1,068	645	574	891	817	789	676	125
Net Nonoperating Expense (NNE)	5.93	4.66	5.88	2.71	7.83	8.19	5.37	5.09	3.38	7.73
Net Nonoperating Obligations (NNO)	550	605	719	816	683	771	875	897	780	956
Total Depreciation and Amortization (D&A)	25	24	24	25	26	26	27	27	29	31
Debt-free, Cash-free Net Working Capital to Revenue	9.88%	10.92%	12.64%	14.22%	9.65%	9.72%	10.31%	10.08%	4.73%	7.87%
Debt-free Net Working Capital to Revenue	23.97%	32.85%	32.56%	24.80%	22.69%	21.92%	21.45%	22.66%	19.52%	19.82%
Net Working Capital to Revenue	23.42%	23.71%	23.28%	14.27%	12.81%	20.09%	18.53%	17.97%	15.47%	2.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.80	$0.75	$0.68	$0.65	$1.60	$0.65	$0.63	$0.58	$0.49	$0.52
Adjusted Weighted Average Basic Shares Outstanding	178.39M	177.60M	179.65M	180.42M	182.35M	181.40M	183.23M	183.80M	184.18M	183.31M
Adjusted Diluted Earnings per Share	$0.80	$0.74	$0.67	$0.64	$1.57	$0.64	$0.63	$0.57	$0.48	$0.51
Adjusted Weighted Average Diluted Shares Outstanding	180.44M	179.71M	180.91M	181.94M	185.14M	183.80M	185.83M	187.59M	188.09M	187.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	175.67M	176.36M	178.18M	179.98M	180.73M	181.41M	181.32M	184.15M	183.98M	183.26M
Normalized Net Operating Profit after Tax (NOPAT)	148	137	128	120	114	126	122	111	93	104
Normalized NOPAT Margin	11.84%	11.35%	10.87%	10.58%	9.94%	11.07%	11.00%	10.21%	8.44%	9.32%
Pre Tax Income Margin	14.62%	14.49%	13.81%	13.82%	13.83%	13.64%	13.60%	12.71%	11.17%	10.90%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	21.12%	16.07%	16.14%	15.92%	15.84%	22.84%	23.55%	25.86%	25.99%	26.42%
Augmented Payout Ratio	70.31%	16.07%	16.14%	15.92%	51.57%	22.84%	23.55%	25.86%	86.56%	26.42%

Frequently Asked Questions About Genpact's Financials

When does Genpact's financial year end?

According to the most recent income statement we have on file, Genpact's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Genpact's net income changed over the last 9 years?

Genpact's net income appears to be on an upward trend, with a most recent value of $513.67 million in 2024, rising from $239.82 million in 2015. The previous period was $631.26 million in 2023. See where experts think Genpact is headed by visiting Genpact's forecast page.

What is Genpact's operating income?

Genpact's total operating income in 2024 was $702.06 million, based on the following breakdown:

Total Gross Profit: $1.69 billion
Total Operating Expenses: $988.01 million

How has Genpact revenue changed over the last 9 years?

Over the last 9 years, Genpact's total revenue changed from $2.46 billion in 2015 to $4.77 billion in 2024, a change of 93.7%.

How much debt does Genpact have?

Genpact's total liabilities were at $2.60 billion at the end of 2024, a 1.6% increase from 2023, and a 74.4% increase since 2015.

How much cash does Genpact have?

In the past 9 years, Genpact's cash and equivalents has ranged from $368.40 million in 2018 to $899.46 million in 2021, and is currently $648.25 million as of their latest financial filing in 2024.

How has Genpact's book value per share changed over the last 9 years?

Over the last 9 years, Genpact's book value per share changed from 6.13 in 2015 to 13.55 in 2024, a change of 120.9%.

Related Companies

This page (NYSE:G) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genpact (G) Financials

Frequently Asked Questions About Genpact's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Genpact (G) Financials

Annual Income Statements for Genpact

Quarterly Income Statements for Genpact

Annual Cash Flow Statements for Genpact

Quarterly Cash Flow Statements for Genpact

Annual Balance Sheets for Genpact

Quarterly Balance Sheets for Genpact

Annual Metrics And Ratios for Genpact

Quarterly Metrics And Ratios for Genpact

Frequently Asked Questions About Genpact's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools